Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial.
Saved in:
| Title: | Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial. |
|---|---|
| Authors: | Fujiwara, Masaki (AUTHOR), Yamada, Yuto (AUTHOR), Shimazu, Taichi (AUTHOR), Kodama, Masafumi (AUTHOR), So, Ryuhei (AUTHOR), Matsushita, Takanori (AUTHOR), Yoshimura, Yusaku (AUTHOR), Horii, Shigeo (AUTHOR), Fujimori, Maiko (AUTHOR), Takahashi, Hirokazu (AUTHOR), Nakaya, Naoki (AUTHOR), Kakeda, Kyoko (AUTHOR), Miyaji, Tempei (AUTHOR), Hinotsu, Shiro (AUTHOR), Harada, Keita (AUTHOR), Okada, Hiroyuki (AUTHOR), Uchitomi, Yosuke (AUTHOR), Yamada, Norihito (AUTHOR), Inagaki, Masatoshi (AUTHOR) |
| Source: | Acta Psychiatrica Scandinavica. Oct2021, Vol. 144 Issue 4, p318-328. 11p. 1 Diagram, 3 Charts. |
| Subjects: | Colorectal cancer, Early detection of cancer, Fecal occult blood tests, Schizophrenia |
| Geographic Terms: | Japan |
| Abstract: | Objective: We examined the efficacy of a case management approach to improve participation in colorectal cancer screening among people with schizophrenia. Methods: This was a randomized, parallel group trial. We recruited outpatients with schizophrenia aged 40 years or over from two psychiatric hospitals in Japan. Participants were randomly assigned (1:1) to treatment as usual or case management intervention plus treatment as usual using a web‐based system. Attending clinicians and participants were unmasked to the allocation. Case management included education and patient navigation for colorectal cancer screening using a fecal occult blood test. Treatment as usual included direct mail government recommendations. The primary endpoint was participation in colorectal cancer screening assessed using municipal records. We also assessed the secondary endpoint of participation in other cancer screenings (lung, gastric, breast, and cervical). Results: Between 3 June and 9 September 2019, 172 eligible participants were randomly assigned to the case management plus treatment as usual group (n = 86) or treatment as usual group (n = 86). One participant was ineligible and another withdrew consent; both were excluded from analysis. A significantly higher proportion of participants received colorectal cancer screening in the case management plus treatment as usual group than in the treatment as usual group (40 [47.1%] of 85 participants vs. 10 [11.8%] of 85 participants, p < 0.0001). The proportion of lung cancer screening also increased. No serious adverse events associated with the study intervention occurred. Conclusion: The case management intervention to encourage participation in colorectal cancer screening was effective for patients with schizophrenia. [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Objective: We examined the efficacy of a case management approach to improve participation in colorectal cancer screening among people with schizophrenia. Methods: This was a randomized, parallel group trial. We recruited outpatients with schizophrenia aged 40 years or over from two psychiatric hospitals in Japan. Participants were randomly assigned (1:1) to treatment as usual or case management intervention plus treatment as usual using a web‐based system. Attending clinicians and participants were unmasked to the allocation. Case management included education and patient navigation for colorectal cancer screening using a fecal occult blood test. Treatment as usual included direct mail government recommendations. The primary endpoint was participation in colorectal cancer screening assessed using municipal records. We also assessed the secondary endpoint of participation in other cancer screenings (lung, gastric, breast, and cervical). Results: Between 3 June and 9 September 2019, 172 eligible participants were randomly assigned to the case management plus treatment as usual group (n = 86) or treatment as usual group (n = 86). One participant was ineligible and another withdrew consent; both were excluded from analysis. A significantly higher proportion of participants received colorectal cancer screening in the case management plus treatment as usual group than in the treatment as usual group (40 [47.1%] of 85 participants vs. 10 [11.8%] of 85 participants, p < 0.0001). The proportion of lung cancer screening also increased. No serious adverse events associated with the study intervention occurred. Conclusion: The case management intervention to encourage participation in colorectal cancer screening was effective for patients with schizophrenia. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 0001690X |
| DOI: | 10.1111/acps.13348 |
